Investigational Site Number : 7240001

Pamplona, Navarre 31008

1 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Metastatic Neoplasm, Neoplasm Malignant, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma, Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation
• First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL — Completed
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) — Completed
• A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Stopped early